A novel nitro-oxy substituted analogue of rofecoxib reduces human colon cancer cell growth.

Molecular and cellular biochemistry

Volumn 361, Issue 1-2, 2012, Pages 105-110

  Bocca, Claudia ^a   Bozzo, Francesca ^b   Ievolella, Monica ^b   Miglietta, Antonella ^b  

^a UNIVERSITY OF TURIN   (Italy)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; BETA CATENIN; CADHERIN; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITOR; DRUG DERIVATIVE; GAMMA BUTYROLACTONE; MITOGEN ACTIVATED PROTEIN KINASE; MYC PROTEIN; MYC PROTEIN, HUMAN; NITRATE; NO ROFE; NO-ROFE;

ARTICLE; CELL PROLIFERATION; CELL SURVIVAL; COLON TUMOR; DRUG EFFECT; GENE EXPRESSION; GENETICS; HUMAN; METABOLISM; PHOSPHORYLATION; TUMOR CELL LINE;

4-BUTYROLACTONE; ANTINEOPLASTIC AGENTS; BETA CATENIN; CADHERINS; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; COLONIC NEOPLASMS; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITORS; GENE EXPRESSION; HUMANS; MITOGEN-ACTIVATED PROTEIN KINASES; NITRATES; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-MYC;

EID: 85027949820     PISSN: None     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-011-1094-9     Document Type: Article

References (0)